Diagnostic utility of neuropsychological performance and quantitative MRI-based measurement in Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 18, Issue 3, 2004, Pages 163-170

  Wang, Huali ^a,c   Shu, Liang ^a   Xie, Jingxia ^b   Zhang, Hongyan ^a   Zhang, Dai ^a  

^a PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer disease; Cognitive impairment; Diagnosis; Magnetic resonance imaging; Medial temporal lobe; Vascular dementia

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFORMANCE; PRIORITY JOURNAL; RATING SCALE; TEMPORAL LOBE;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 4444353485     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wad.0000137521.61487.68     Document Type: Article

References (28)

1. Almkvist O. Neuropsychological features of early Alzheimer's disease: preclinical and clinical stages. Acta Neurol Scand Suppl. 1996;165:63-71.
2. Almkvist O, Basun H, Backman L, et al. Mild cognitive impairment: an early stage of Alzheimer's disease? J Neural Transm Suppl. 1998;54:1-29.
3. Howieson DB, Dame A. Camicioli R, et al. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc. 1997:45:584-589.
4. Storandt M, Hill RD. Very mild senile dementia of the Alzheimer type: II. Psychometric test performance. Arch Neurol. 1989;46:383-386.
5. Welsh KA, Butters N, Hughes JP, et al. Detection and staging of dementia in Alzheimer's disease: use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol. 1992;49:448-452.
6. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl). 1991;82:239-259.
7. DeCarli C, Murphy DG, McIntosh AR, et al. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. Psychiatry Res. 1995;57:119-130.
8. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRl in normal aging and very mild Alzheimer's disease. Neurology. 1997;49:786-794.
9. Laakso MP, Soininen H, Partanen K, et al. MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging. 1998;19:23-31.
10. Petersen RC, Jack CR Jr, Xu YC, et al. Memory and MRI-based hippocampal volumes in aging and AD. Neurology. 2000;54:581-587.
11. Xu Y, Jack CR Jr, O'Brien PC, et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology. 2000;54:1760-1767.
12. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
13. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
14. Li G, Shen YC, Chen CH, et al. A three-year follow-up study of age-related dementia in an urban area of Beijing. Acta Psychiatr Scand. 1991;83:99-104.
15. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984;141:1356-1364.
16. Wang HL, Shu L, Si TM, et al. Clinical validity and reliability of Chinese version of ADAS. Chin Clin Psychol J. 2000;8:89-93.
17. Gong Y. Wechsler Memory Scale-Revised [in Chinese]. Changsha, China: Hunan Scientific, 1989.
18. Reisberg B, Ferris SH, de Leon MJ, et al. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136-1139.
19. Lehericy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. Am J Neuroradiol. 1994;15:929-937.
20. Mu Q, Xie J, Wen Z, et al. A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age. Am J Neuroradiol. 1999;20:207-211.
21. Kirsch SJ, Jacobs RW, Butcher LL, et al. Prolongation of magnetic resonance T2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease. Neurosci Lett. 1992;134:187-190.
22. Duncan JS, Bartlett P, Barker GJ. Technique for measuring hippocampal T2 relaxation time. Am J Neuroradiol. 1996;17:1805-1810.
23. Doraiswamy PM, Bieber F, Kaiser L, et al. Memory, language, and praxis in Alzheimer's disease: norms for outpatient clinical trial populations. Psychopharmacol Bull. 1997;33:123-128.
24. Wang H, Zhang H, Shu L, et al. Comparative study on clinical scale assessment between Alzheimer's disease, vascular dementia and normal aging. Neurobiol Aging. 2000;21(suppl.):163.
25. Jack CR Jr, Petersen RC, O'Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology. 1992;42:183-188.
26. Juottonen K, Laakso MP, Insausti R, et al. Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease. Neurobiol Aging. 1998;19:15-22.
27. Juottonen K, Laakso MP, Partanen K, et al. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. Am J Neuroradiol. 1999;20:139-144.
28. Laakso MP, Frisoni GB, Kononen M, et al. Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study. Biol Psychiatry. 2000;47:1056-1063.